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Global proﬁling of protein–DNA and
protein–nucleosome binding afﬁnities using
quantitative mass spectrometry
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Till Bartke3,4,5 & Michiel Vermeulen 1,2
Interaction proteomics studies have provided fundamental insights into multimeric
biomolecular assemblies and cell-scale molecular networks. Signiﬁcant recent developments
in mass spectrometry-based interaction proteomics have been fueled by rapid advances in
label-free, isotopic, and isobaric quantitation workﬂows. Here, we report a quantitative
protein–DNA and protein–nucleosome binding assay that uses afﬁnity puriﬁcations from
nuclear extracts coupled with isobaric chemical labeling and mass spectrometry to quantify
apparent binding afﬁnities proteome-wide. We use this assay with a variety of DNA and
nucleosome baits to quantify apparent binding afﬁnities of monomeric and multimeric
transcription factors and chromatin remodeling complexes.
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Interaction proteomics, via mass spectrometry, has contributedinvaluably to the identiﬁcation of physical associationsbetween biological molecules and the translation thereof into
cellular protein networks1–3. Interaction proteomics methodolo-
gies are generally semi-quantitative and use label-free or chemical
labeling-based relative quantiﬁcation to call interactions as
outliers from a background of non-speciﬁc identiﬁcations4,5.
Thus, interactions are regularly reported in a binary on/off
manner, though semi-quantitative stoichiometric information is
beginning to add a quantitative dimension to interaction studies.
Nevertheless, a complete characterization of a functioning cell
requires knowledge not only of speciﬁcity of biomolecular
interactions (i.e., does an interaction occur, or not) but also of
afﬁnity (i.e., how strong, in absolute terms, is some given
interaction)6. Typical afﬁnity quantitation methods, such as
isothermal titration calorimetry, surface plasmon resonance,
ﬂuorescence polarization, ﬂuorescence resonance energy transfer,
or electrophoretic mobility shift assay (EMSA), have been per-
formed on a single interaction, case-by-case basis, and require
laborious expression and puriﬁcation of recombinant proteins.
Importantly, chemoproteomic approaches studying protein–small
molecule interactions established the possibility of designing
absolutely quantitative binding assays using semi-quantitative
isobaric labeling and mass spectrometry7,8. Similarly, thermal
proteome proﬁling is an innovative mass spectrometry approach
that uses thermal stability shifts upon small-molecule binding to
estimate apparent dissociation constants proteome-wide, again
with a semi-quantitative isobaric labeling strategy9,10. Other
protein-centric studies have focused on measuring the DNA-
binding landscape of a single, or a few, transcription factors11,12.
However, the inverse problem of interrogating the quantitative
protein binding landscape of DNA sequences of interest has
received considerably less attention and is still dominated by
semi-quantitative workﬂows13,14. Here, we present a method for
determining, proteome-wide, tens to hundreds of apparent
dissociation constants (KdApp) of nuclear proteins for DNA and
nucleosome ligands simultaneously using afﬁnity puriﬁcation
from nuclear lysates and isobaric 10-plex tandem mass tag (TMT)
labeling coupled with mass spectrometry.
Results
Benchmarking KdApp measurements with the SP/KLF motif.
We ﬁrst afﬁnity puriﬁed nuclear proteins from isolated nuclear
lysates using a series of ten pulldowns with different concentra-
tions of oligonucleotide baits coupled to streptavidin–sepharose
beads. Proteins binding at each titration point were digested to
tryptic peptides and isobarically labeled with the 10-plex TMT
system15. Labeled peptides were combined and measured in a
single synchronous precursor selection-MS3 (SPS-MS3) mass
spectrometry run16,17 (Fig. 1a). Critically, the highest titration
point (labeled with TMT131) represented a pulldown at micro-
molar concentration. We assumed that proteins with nanomolar
range apparent dissociation constants (KdApp ~ 1–500 nM) would
exhibit saturated binding at this concentration. Thus, for each
DNA concentration we calculated the bound fraction for each
individual protein compared to the TMT131 reporter ion signal
(Fig. 1b and Supplementary Fig. 1). KdApp values were
determined independently for each protein by ﬁtting the para-
meters of a Hill-like curve using the known DNA concentrations
and the observed fraction bound (Fig. 1a). We ﬁltered out
background or non-speciﬁc proteins based on the quality of ﬁt of
the Hill curve, under the assumption that background proteins
would show randomly distributed ratios near 1:1 for all titration
points. As such, only proteins ﬁtting a Hill-like curve with an r2
value >0.95 were kept for downstream analysis. As each bait
proﬁled required a set of ten pulldowns conducted in triplicate or
duplicate for ﬁtting, we utilized a ﬁlter plate system to increase
throughput18. We note that this system is amenable to automa-
tion in future high-throughput studies.
As a benchmark case, we quantitatively proﬁled the nuclear
protein binding landscape of the well-characterized SP/KLF
consensus GC-box18. Oligo depletion was essentially complete
after bead immobilization (Supplementary Fig. 2A). Binding of
canonical SP/KLF factors was strongly speciﬁc for the designed
SP/KLF motif oligonucleotide, with essentially no background
binding observed for a mutated SP/KLF motif (Supplementary
Fig. 2B). Using an r2 value of 0.95 as a ﬁltering criterion, we
observed low coefﬁcients of variation for ﬁtted KdApp values
(Fig. 1c). We estimated the KdApp value for canonical SP/KLF
binding factor SP1 as ~38 nM and conﬁrmed this result in lysates
with gel-based assays (Fig. 1d and Supplementary Fig. 2C).
Furthermore, we estimated KdApp values for a number of other
SP/KLF family factors including SP3 and KLF4. Interestingly,
puriﬁed recombinant SP3 exhibited a substantially lower Kd in
gel-shift assays indicating a higher afﬁnity compared to
mass spectrometry-based measurements from nuclear lysates
(Supplementary Fig. 2D). However, this shift was abrogated when
recombinant SP3 was spiked into nuclear lysates, where
recombinant and endogenous SP3 showed comparable binding
curves. Similarly, we observed a lower Kd value for the SP/KLF
motif and puriﬁed recombinant KLF4-ZF domain using
ﬂuorescence polarization and ﬂuorescence de-quenching
assays compared to those measured for endogenous KLF4
in lysates by mass spectrometry and gel-based assays (Supple-
mentary Fig. 3)19,20. This clearly suggests competitive inhibition
between proteins in the nuclear environment as has been reported
for SP1-KLF4 and SP1-KLF16 among other SP/KLF factors21. As
such, this complex interplay between DNA binding proteins
indicates KdApp measurements will be useful information for
uncovering interactions within transcriptional networks as they
exist in the in vivo nuclear environment.
To further characterize the speciﬁcity and sensitivity of this
assay, we conducted a series of competition experiments with free
(unbiotinylated) wild-type and mutated SP/KLF oligonucleotides.
In agreement with western blot analysis (Supplementary Fig. 2B),
known sequence-speciﬁc SP/KLF transcription factors showed no
measurable binding to the mutated SP/KLF oligonucleotide
(Supplementary Fig. 4A). In competition experiments, these
sequence-speciﬁc factors were similarly not competed away from
immobilized wild-type oligonucleotides by free mutated
oligonucleotides (Supplementary Fig. 4A). Yet, importantly,
KdApp values for sequence-speciﬁc proteins estimated by
applying the Cheng–Prusoff correction to IC50 values from
competition experiments (Supplementary Fig. 4B) were
highly correlated to KdApp values estimated with immobilized
oligonucleotides at a near 1:1 ratio (Supplementary Fig. 4C). In
contrast, non-sequence-speciﬁc proteins bound to immobilized
wild-type or mutated SP/KLF oligos with high correlation
(Supplementary Fig. 4A). Non-sequence-speciﬁc proteins were
also competed from immobilized wild-type oligonucleotides by
either wild-type of mutated free oligonucleotide. However,
non-sequence-speciﬁc proteins displayed lower KdApp values on
average to either free oligonucleotide compared to immobilized
oligonucleotides in competition experiments (Supplementary
Fig. 4C). We attribute this to free oligonucleotides having two
available blunt ends acting as substrates for some non-sequence-
speciﬁc proteins, while immobilized oligonucleotides only
have one sterically free blunt end. This is an important
consideration for future studies comparing free vs. immobilized
oligonucleotides and sequence-speciﬁc vs. non-speciﬁc DNA-
binding factors.
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The KdApp values we measured did not signiﬁcantly correlate
with absolute protein abundance, demonstrating that the KdApp
values we measured were not biased by protein abundance
(Supplementary Fig. 4D and Supplementary Data 2)22,23. An
additional analysis taking possible phospho-post-translational
modiﬁcations into account also showed practically no difference
with our original result, suggesting such phospho-modiﬁcations,
even if stoichiometric in vivo, may not be easily identiﬁed without
speciﬁc enrichment methods (Supplementary Fig. 4E)24. Finally,
we calculated JASPAR transcription factor binding proﬁle
motif scores for sequence-speciﬁc proteins with JARPAR motifs
and correlated them with the KdApp values we measured
(Supplementary Fig. 5). We observed signiﬁcant correlation,
demonstrating that our assay produced results consistent with
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Fig. 1 Benchmarking protein–DNA KdApp measurements with the SP/KLF consensus motif. a A titration series of a known concentration of bait is used for
afﬁnity puriﬁcation of proteins from nuclear lysates. Bound proteins are digested with trypsin, isobarically labeled with TMT reagent, and analyzed by mass
spectrometry. Quantiﬁcation of binding interactions yields a Hill-like curve, as described in the Methods, which can be used to calculate the KdApp. b SPS-
MS3 TMT reporter ion spectrum of an example SP1 peptide. Only the low m/z range of the MS3 spectrum, where the TMT reporter ions are observed, is
displayed for clarity. Plotted on the y-axis are signal-to-noise values measured in the orbitrap at 60,000 resolution. c Boxplot analysis of all coefﬁcients of
variation for ﬁtted KdApp values identiﬁed using the SP/KLF consensus motif with r2 values >0.95. The box represents the quartiles of the data, while
the whiskers represent the range of 1.5 IQRs. The center line is the median of the distribution. d Hill-like curve identiﬁed for SP1 binding to the consensus
SP/KLF GC-box motif. Binding curves were generated by ﬁtting the parameters of the Hill equation including KdApp. Each data point is the mean of three
experiments (n= 3), and the error bars represent the standard error of the mean
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motif-based binding landscape models. Summarily, on these
bases we concluded that our assay generated reliable KdApp
measurements for protein–DNA interactions in this SP/KLF
benchmark case.
Chromatin remodelers quantitatively prefer G-quadruplexes.
Next, we conducted a larger assay of eight different double-
stranded DNA (dsDNA) or single-stranded DNA (ssDNA)
(Fig. 2a and Supplementary Table 1) sequences representing
canonical, well-characterized biological motifs (AP-1, CTCF, E-
box, NF-Y, TATA, TEAD, the human ssDNA telomere repeat,
and the c-Myc promoter Pu27 G4-quadruplex forming ssDNA
sequence [mycG4]25). We observed numerous homo-multimeric
and hetero-multimeric transcription factors and DNA-binding
proteins binding to their canonical motif in readily distinguish-
able clusters, including JUNB/JUND, MAX, POT1, and TEAD/
YAP (Fig. 2a–e). More speciﬁcally, we were surprised and
intrigued to see subunits of many chromatin-modifying
complexes binding to the mycG4 sequence in G4-permissive
NaCl-based binding buffer, including SWItch/Sucrose Non-
Fermentable (SWI/SNF) and Imitation SWI (ISWI) subunits
(Fig. 2f, g). This immediately suggested the possibility that some
chromatin remodeling and modifying enzymes speciﬁcally
recognize DNA G4 structures. To further characterize these
interactions, we performed an additional set of assays using either
150 mM LiCl buffer, which destabilizes G-quadruplex structures,
or 150 mM NaCl binding buffer supplemented with 20 μM
PhenDC3, which stabilizes G4 structures (Fig. 2a). Both LiCl and
G-quadruplex stabilizing small molecules were shown previously
to inhibit G4-RNA binding of polycomb repressive complex 2
(PRC2)26, which binds RNA G-quadruplexes through interfaces
on EZH2 and EED subunits and an RNA recognition motif in the
SUZ12 subunit27,28. Here, we observed that KdApp values mea-
sured for the mycG4 sequence in LiCl and PhenDC3 binding
conditions were indeed positively correlated (Supplementary
Fig. 6A). LiCl or PhenDC3 treatment quantitatively and
signiﬁcantly increased KdApp values for both SWI/SNF and ISWI
subunits and for PRC2 and nucleosome remodeling and
deacetylase (NuRD) subunits (Fig. 2f, g and Supplementary
Fig. 6B, C). Among these, PRC2 and NuRD subunits bound with
~100 nM KdApps to the mycG4 sequence, similar to the recently
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Fig. 2 A motif survey identiﬁes SWI/SNF and ISWI factors binding to G4-quadruplex structures. a Heatmap analysis KdApp binding proﬁles for all dsDNA
and ssDNA sequences and experiments. Proteins were clustered (15 clusters) using hierarchical agglomerative clustering. The heatmap is colored by the
average log 10[KdApp] value of the cluster per bait. Cluster labels and number of proteins per cluster (n) are listed in columns to the left of the heatmap. b–g
KdApp binding curves for canonical and unreported binding proteins for some example dsDNA and ssDNA motifs. b KdApp binding curve for AP-1 dsDNA
motif and dimeric binding factors JUNB (Cluster 15) and JUND (Cluster 3). c KdApp binding curve for E-box dsDNA motif and dimeric binding factor MAX
(Cluster 2). d KdApp binding curve for TEAD dsDNA motif and dimeric binding factors TEAD4 (Cluster 4) and YAP1 (Cluster 4). e KdApp binding curve for
the telomere ssDNA motif (four repeats) and binding factor POT1 (Cluster 11). f KdApp binding curve for the mycG4 ssDNA motif in NaCl (G4-permissive),
LiCl (G4-nonpermissive), and PhenDC3 (G4-ligand) binding conditions and SWI/SNF binding factor SMARCA4 (Cluster 7). g KdApp binding curve for the
mycG4 ssDNA motif in NaCl, LiCl, and PhenDC3 binding conditions and ISWI binding factor SMARCA5 (Cluster 7). For b–g, binding curves were
generated by ﬁtting the parameters of the Hill equation including KdApp. Each data point is the mean of two experiments (n= 2), and the error bars
represent the standard error of the mean
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reported binding afﬁnity of PRC2 to RNA G-quadruplexes26,27.
Further supporting this ﬁnding, we detected enrichment of
induced G-quadruplex structures in both SWI/SNF, PRC2, and
NuRD subunit binding sites in a variety of ENCODE ChIP-
sequencing (ChIP-seq) datasets, consistent with our in vitro
binding data (Supplementary Fig. 6D)29–31. We also veriﬁed this
ﬁnding by western blot (Supplementary Fig. 7A–C). Finally, we
were interested in identifying potential direct G4 DNA-binding
subunits from these chromatin remodeling and modifying com-
plexes. We adapted a formaldehyde cross-linking approach to
identify individual peptides immediately proximal to the mycG4
DNA bait (Supplementary Fig. 8A)32. Identiﬁed peptides from a
known DNA-binding complex were proximal to the DNA-
binding channel, indicating the reliability of the approach (Sup-
plementary Fig. 8B, PDB: 1JEY (https://doi.org/10.2210/pdb1JEY/
pdb))33. We identiﬁed a peptide from the N-terminal winged
helix-like domain (WHD) of SMARCB1 as the most signiﬁcantly
enriched for direct G4 binding of SWI/SNF, ISWI, PRC2, and
NuRD subunits (Supplementary Fig. 8C–E). Afﬁnity puriﬁcation
experiments with the recombinant SMARCB1-WHD veriﬁed that
the SMARCB1-WHD speciﬁcally recognizes the mycG4 bait
compared to a variety of control baits while the double plant
homeodomain (PHD) ﬁnger of PHF10, another SWI/SNF
accessory subunit, does not (Supplementary Fig. 8F)34. Overall,
these in vitro analyses provide biochemical support for the
hypothesis that some chromatin remodelers and modiﬁers can
bind G4 DNA sequences in a G-quadruplex preferential manner.
KdApp estimation using nucleosome substrates. Finally, to show
that this binding assay is compatible not only with nucleic acids
but also with nucleoprotein complexes, we performed a set of
experiments using mono-nucleosomes, di-nucleosomes, and
modiﬁed di-nucleosomes (Fig. 3a and Supplementary Fig. 9A–D).
We identiﬁed a number of protein–di-nucleosome interactions
that were either speciﬁc to or modulated by either H3K4me3 or
H3K9AcK14Ac (Fig. 3b, d, e). Across all baits, coefﬁcients of
variation were reasonably low indicating good data quality
(Fig. 3c). We observed SWI/SNF and ISWI binding with sig-
niﬁcantly lower KdApp to H3K9AcK14Ac-containing di-nucleo-
somes compared to unmodiﬁed di-nucleosomes (Supplementary
Fig. 10A, D). Indeed, many accessory SWI/SNF subunits were
uniquely identiﬁed with the H3K9AcK14Ac di-nucleosome bait.
We identiﬁed one SWI/SNF subunit, PHF10, which harbors a
C-terminal double PHD ﬁnger (DPF) and may preferentially
interact with H3K9AcK14Ac compared to unmodiﬁed H3 or
H3K4me3 as has been reported for another DPF domain35.
PHF10 shows one of the lowest KdApp values of all identiﬁed
SWI/SNF subunits (~35 nM, Fig. 3e) for H3K9AcK14Ac
di-nucleosomes and was similarly identiﬁed exclusively with the
H3K9AcK14Ac di-nucleosome. To further investigate the
H3K9AcK14Ac speciﬁcity of PHF10, we used bacterial lysates
expressing the recombinant glutathione S-transferase (GST)-tag-
ged DPF domain of PHF10 in histone H3 peptide pull-down
experiments (Supplementary Fig. 10B). This experiment clearly
conﬁrmed that recombinant PHF10-DPF binding to H3 is
strongly agonized by H3K9AcK14Ac in contrast to the
SMARCB1-WHD, as has been reported for the bromodomain of
Swi2/Snf2 and the DPF domains of SWI/SNF accessory subunits
DPF2 and DPF3 (Supplementary Fig. 10C)36–38. Thus, PHF10
represents an additional high afﬁnity H3 acetylation reader in the
human SWI/SNF complex. Intriguingly, PHF10-DPF seems to be
repelled by H3K4me3, and our data suggests this might confer a
lower afﬁnity ﬁne-tuning on PHF10-SWI/SNF nucleosome
binding. However, even in the absence of the acetylation
speciﬁcity conferred by SWI/SNF acetylation reader domains, we
observed that catalytic SWI/SNF subunits SMARCA2 and
SMARCA4 still engage in relatively high afﬁnity interactions
with H3K4me3 modiﬁed and unmodiﬁed di-nucleosomes
(Supplementary Fig. 10A, D). Similarly, we observed relatively
high afﬁnity interactions between modiﬁed or unmodiﬁed di-
nucleosomes and ISWI catalytic subunit SMARC5 and ISWI
accessory subunits including BPTF, C17orf49 (Fig. 3e), BAZ1A,
and BAZ1B. The binding patterns we observe between different
di-nucleosome baits are complex and highlight an important
point and a unique beneﬁt of measuring apparent afﬁnities from
complex lysates: we measure the average binding proﬁle over
what is likely a pool of heterogeneous multimeric protein com-
plexes. For example, we observe catalytic subunit SMARCA5
binding with highest afﬁnity to H3K9AcK14Ac di-nucleosomes
compared to unmodiﬁed or H3K4me3 di-nucleosomes (Supple-
mentary Fig. 10D). Yet, accessory subunits BPTF, C17orf49,
BAZ1A, and BAZ1B exhibit binding curves that are both similar
to and distinct from the binding curve of SMARCA5 depending
on the accessory subunit and di-nucleosome pair in question,
suggesting these subunits regulate differential H3 modiﬁcation-
speciﬁc binding (Supplementary Fig. 10D). Moreover, these ISWI
accessory subunits, along with SMARCA5, form at least three
unique and independent protein complexes (the NuRF, ACF,
and WICH complexes)39. More generally, deconvoluting the
individual contributions of different subcomplexes with recom-
binant systems is indisputably critical (e.g., as with SMARCB1
and its G-quadruplex interaction and PHF10-H3K9AcK14Ac
binding in SWI/SNF). In the future, a data-driven strategy for
assessing the contributions of shared subunits within independent
subcomplexes might involve a combinatorial approach utilizing
many DNA or modiﬁed nucleosome baits as was demonstrated,
for example, with the stoichiometry of different SET1/MLL
subcomplexes22. Additionally, we argue that the ability to
measure binding afﬁnities for multimeric complexes in the
complex environment of the nucleus offers an important holistic,
system-wide view.
Discussion
By measuring protein–DNA and protein–nucleosome KdApp
values via mass spectrometry, we provide another avenue for
extending protein–nucleic acid interaction proteomics beyond
comparative, semi-quantitative workﬂows. From a systems
biology perspective, absolute binding afﬁnities within the nuclear
environment create a quantitative link between transcription
factor expression and target gene regulation via the TF–DNA
interaction. However, our data imply a situation where DNA
sequences, structures, and chromatinized DNA integrate signals
from a variety of binding partners at a spectrum of biologically
relevant afﬁnities. Indeed, we observe that both DNA structures,
including G-quadruplexes, and (modiﬁed) nucleosomes engage in
high afﬁnity-binding interactions with various independent
chromatin remodeling and modifying complexes. Of note, we
observe SWI/SNF as a complex that recognizes both DNA
structure and histone modiﬁcation state, and we identify
SMARCB1 and PHF10, respectively, as speciﬁc readers that
contribute to these high afﬁnity substrate recognitions. While
targeted biochemical analysis reveals direct mediators of speciﬁc
substrate interactions within a complex, combining these analyses
with afﬁnity measurements in the context of multimeric assem-
blies in complex lysates takes into consideration the possibility of
larger molecular regulatory networks. This work demonstrates an
assay for revealing not only these regulatory interactions but also
their absolute afﬁnities and thereby proﬁling the proteome-wide
quantitative binding landscape of nuclear proteins for DNA
oligonucleotides and nucleosome complexes.
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Fig. 3 Quantitative analysis of modiﬁed di-nucleosome interactions. a Schematic representation of KdApp di-nucleosome and modiﬁed di-nucleosome
study design. b Heatmap analysis of KdApp binding proﬁles for all nucleosome, di-nucleosome, and modiﬁed di-nucleosome experiments. Proteins
were clustered (ﬁve clusters) using hierarchical agglomerative clustering. The heatmap is colored by the average log 10[KdApp] value of the cluster
per bait. Cluster labels and number of proteins per cluster (n) are listed in columns to the left of the heatmap. c Boxplot analysis of all coefﬁcients of
variation for ﬁtted KdApp values identiﬁed in nucleosome experiments with r2 values >0.90. The box represents the quartiles of the data, while the
whiskers represent the range of 1.5 IQRs. The center line is the median of the distribution. d, e Example KdApp binding curves for binding proteins of
H3K4me3 and H3K9AcK14Ac di-nucleosomes. d KdApp binding curve for H3K4me3 modiﬁed di-nucleosomes and binding factor C17orf49 (Cluster 1).
e KdApp binding curve for H3K9AcK14Ac modiﬁed di-nucleosomes and binding factor PHF10 (Cluster 3). Binding curves were generated by ﬁtting
the parameters of the Hill equation including KdApp. Each data point is the mean of three experiments (n= 3), and the error bars represent the standard
error of the mean
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Methods
Cell culture and nuclear lysate preparation. Wild-type HeLa Kyoto cells
(received from Anthony Hyman and Ina Poser, Human HeLa BAC database,
Dresden, Germany) were cultured in Dulbecco's modiﬁed Eagle's medium sup-
plemented with 10% fetal bovine serum and 100 U/mL penicillin and streptomycin.
Cells were periodically tested for mycoplasma contamination. Nuclear lysates were
isolated as described previously14. Brieﬂy, cells were lysed by swelling and
mechanical force in buffer A (10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM
KCl, and 0.15% NP40). Then, nuclei were collected by centrifugation and
chemically lysed in buffer C (420 mM NaCl2, 20 mM HEPES (pH 7.9), 20% (v/v)
glycerol, 2 mM MgCl2, 0.2 mM EDTA, 0.1% NP40, EDTA-free complete protease
inhibitors (CPIs, Roche), and 0.5 mM dithiothreitol (DTT)). Protein concentra-
tions were assessed by Bradford assay.
Afﬁnity puriﬁcation and sample preparation. Oligonucleotides for afﬁnity
puriﬁcation were ordered as custom-synthesized oligos from Integrated DNA
Technologies (IDT; Supplementary Table 1). DNA and nucleosome afﬁnity
puriﬁcations were performed using a ﬁlter plate-based workﬂow described ﬁrst by
Hubner et al18. The essential protocol is described below.
First, all dsDNA oligos were annealed by heating to 95 °C for 10 min before
cooling to room temperature. Each oligo was then diluted to a working stock of 3
μM, which represented the highest concentration reference titration point in this
study. A series of nine three-fold dilutions was then prepared, resulting in a
titration series of 10 oligo concentrations ranging from 0.15 nM to 3 μM. We
prepared 200 μL of oligo per titration point per replicate in this fashion. Dilutions
were performed in DNA binding buffer (DBB: 1M NaCl, 10 mM Tris, pH 8, 1 mM
EDTA, 0.05% NP-40).
Filter plates were ﬁrst prepared with 50 μL of ethanol per well (96-well ﬁlter
plate, 1.2 μM pore, Millipore/Merck MSBVS1210). Wells were then washed twice
with DBB. Twenty microliters of streptavidin–sepharose bead slurry was added to
each well (GE, 10 μL beads, 3 nmol binding capacity). Wells were washed twice
with DBB. One hundred and ﬁfty microliters of the corresponding oligo titration
point was added to each well, and oligos were immobilized to the streptavidin-
conjugated beads over a 1 h incubation at 4 °C while shaking on a tabletop
microplate shaker. Samples were then washed once with DBB and twice with
protein binding buffer (PBB: 150 mM NaCl, 50 mM Tris, pH 8, 0.25% NP-40, 1
mM Tris(2-carboxyethyl)phosphine (TCEP), and CPIs). One hundred micrograms
of HeLa nuclear lysate was then diluted to 150 μL ﬁnal volume in PBB and added to
each well. Samples were incubated for 2 h at 4 °C while shaking on a microplate
shaker, and then washed six times with washing buffer (150 mM NaCl, 100 mM
triethylammonium bicarbonate, TEAB).
For competition experiments using SP/KLF wild-type and mutated
oligonucleotides, beads were pre-washed as described and pre-incubated in 96-well
plate format with 200 nM biotinylated SP/KLF wild-type oligonucleotide diluted in
DBB for 1 h at 4 °C while shaking on a tabletop microplate shaker. Free
(unbiotinylated) wild-type or mutated SP/KLF oligonucleotide were prepared at
three-fold diluted concentrations in PBB from 0.3 nM to 6 μM as described above.
One hundred micrograms of HeLa nuclear lysate was prepared in PBB and
oligonucleotides were mixed with HeLa nuclear lysates at a ratio of 1:1 in a ﬁnal
volume of 150 μL, with free oligonucleotides at a ﬁnal concentration of 0.15 nM to
3 μM. Samples were then washed once with DBB and twice with PBB. HeLa lysates
plus free oligonucleotides were added to the beads containing 200 nM immobilized
SP/KLF oligonucleotide. Proteins were incubated for 2 h at 4 °C while shaking on a
microplate shaker, and then washed six times with washing buffer. Sample
preparation for mass spectrometry was continued as described below.
For the LiCl mycG4 experiment, the oligos were heated for 10 min at 95 °C and
afterwards snap-cooled on ice for 3–5 min before they were immobilized on the
beads. The NaCl in the PBB was replaced with 150 mM LiCl for the oligo titration,
protein incubation, and washing steps (PBB composition: 150 mM LiCl, 50 mM
Tris, pH 8, 0.25% NP-40, 1 mM TCEP, and CPIs). For the PhenDC3 mycG4
experiment, 20 μM PhenDC3, ﬁnal concentration, was added to the PBB for oligo
titration, protein incubation, and washing steps (PBB composition: 150 mM NaCl,
50 mM Tris, pH 8, 0.25% NP-40, 1 mM TCEP, CPIs, and 20 μM PhenDC3). For
the nucleosome experiments, nucleosome titration and immobilization was
performed in PBB instead of DBB. All other experimental conditions were the same
as described above.
Sample preparation for mass spectrometry was performed by ﬁrst adding 50 μL
of elution buffer (20% methanol, 80 mM TEAB, 10 mM TCEP). Proteins were
incubated for 30 min at room temperature, alkylated with 50 mM iodoacetamide,
and digested with 0.25 μg trypsin overnight while shaking on a tabletop shaker at
room temperature.
For formaldehye cross-linking experiments using the mycG4 ssDNA
oligonucleotide, 500 μg of HeLa nuclear lysate was prepared in a volume of 600 μL
borate-buffered saline (50 mM boric acid, pH 8.4, 150 mM NaCl, 0.25% NP-40, 1
mM DTT, and CPIs). Five hundred picomoles of mycG4 ssDNA oligonucleotide
was added to each reaction (no DNA was added to duplicate control reactions).
Reactions were incubated for 90 min at 4 °C while rotating end-over-end.
Formaldehyde was added to a 1% ﬁnal concentration, and reactions were incubated
for 10 min at 30 °C. Cross-linking was quenched by adding glycine to a ﬁnal
concentration of 12.5 mM and incubating for 5 min at 30 °C. Twenty microliters of
streptavidin–sepharose bead slurry was added to each reaction, and bead reactions
were incubated for 30 min at 4 °C with rotation. Each reaction was washed three
times with 8 M urea prepared in 50 mM ammonium bicarbonate. Each reaction
was resuspended in 100 μL of 2M urea with 50 mM ammonium bicarbonate and
10 mM DTT. Samples were incubated for 30 min at room temperature with
shaking on a tabletop shaker. Indole-3-acetic acid was added to each reaction to 50
mM and incubated for 10 min in the dark while shaking. Trypsin of 2.5 μg was
added to each sample, and reactions were incubated overnight at room temperature
while shaking. Digested samples were washed three times with 8M urea plus 50
mM ammonium bicarbonate and three times with 50 mM ammonium bicarbonate
to remove digested peptides not cross-linked to DNA oligonucleotides. One
hundred microliters of 50 mM ammonium bicarbonate was added to each sample,
and cross-links were reversed by incubating at 70 °C for 90 min. The supernatant
was collected and transferred to a new tube. Fresh trypsin of 0.25 μg was added to
each sample. Samples were incubated at room temperature for 4 h with shaking,
prepared on stageTips, and labeled by dimethyl chemical labeling on stageTips as
described previously40,41.
Isobaric labeling was performed using the 10-plex TMT system (Thermo)15.
TMT reagent of 0.8 mg for each reporter mass was resuspended in 100 μL
anhydrous acetonitrile. Resuspended TMT reagent of 10 μL was then added to the
corresponding sample. Reactions were incubated for 1 h in the dark before
quenching for 30 min with 100 mM Tris, pH 8.0. All ten pulldowns corresponding
to all ten oligonucleotide titration points labeled by the corresponding TMT
reagent were pooled into one Eppendorf tube, acidiﬁed with triﬂuoroacetic acid,
and desalted for mass spectrometry analysis by the C18 StageTip method42.
Preparation of modiﬁed nucleosomes. Recombinant human core histone pro-
teins were expressed in E. coli BL21(DE3)/RIL cells from pET21b(+) (Novagen)
vectors and puriﬁed by denaturing gel ﬁltration and ion exchange chromatography
essentially as described43. Truncated human H3.1Δ1-31T32C protein for native
chemical ligation of modiﬁed histone H3 variants was expressed in BL21(DE3)/RIL
cells and puriﬁed as described44. Native chemical ligations were carried out in 550
µl of degassed native chemical ligation buffer (200 mM KPO4, 2 mM EDTA, 6 M
guanidine HCl) containing 1 mg of modiﬁed H3.1 amino acids 1–31 thioester
peptide (Cambridge Peptides), 4 mg of truncated H3.1Δ1-31T32C, 12.5 mg 4-
mercaptophenylacetic acid, and 10 mg TCEP as a reducing agent at a pH of 7.5.
The reactions were incubated overnight at 40 °C and quenched by addition of 60 µl
of 1 M DTT and 700 µl of 0.5% acetic acid. After a centrifugation step to remove
precipitates, the ligation reactions were directly loaded and puriﬁed on a reversed
phase chromatography column (Perkin Elmer Aquapore RP-300 C8 250 × 4.6 mm2
i.d.) using a gradient of 45–55% B (buffer A: 0.1% triﬂuoroacetic acid (TFA) in
water; B: 90% acetonitrile, 0.1% TFA) over 10 column volumes. Positive fractions
containing ligated full-length histone H3.1 were then combined and lyophilized.
Histone octamers were refolded from the puriﬁed histones and assembled into
nucleosomes with biotinylated DNA via salt deposition dialysis as described43.
Biotinylated nucleosomal DNAs containing either one (mono-nucleosomes) or two
601 nucleosome positioning sequences45 separated by a 50 bp linker (di-nucleo-
somes) were prepared as described44. Di-nucleosomes were assembled in the
presence of MMTV A competitor DNA and a slight excess of octamers as described
for longer chromatin arrays to ensure saturation of the 601 repeats46. The
reconstituted nucleosomes were then immobilized on magnetic streptavidin beads
(Dynabeads MyOne Steptavidin T1) via the biotinylated DNA, washed to remove
MMTV A competitor DNA and MMTV A nucleosomes (in the case of di-
nucleosomes), and directly used for afﬁnity pull-down reactions as described above.
Nucleosome quality control checks are shown in Supplementary Fig. 9.
Mass spectrometry analysis. Samples containing labeled peptides were eluted
from StageTips with buffer B (80% acetonitrile, 0.1% formic acid), concentrated to
5 μL by SpeedVac centrifugation at room temperature, and resuspended to 12 μL in
buffer A (0.1% formic acid). Samples were separated by liquid chromatography
using an Easy-nLC 1000 system (Thermo). For our ﬁrst SP/KLF replicate, we used
a modiﬁed gradient from 7 to 15% buffer B over 5 min, from 15 to 35% buffer
B over 174 min, from 35 to 50% buffer B over 5 min, and ﬁnally from 50 to 95%
buffer B in 1 min followed by 5 min hold at 95% buffer B. For all other replicates
and experiments, the gradient was the same, with the exception of the 15–35%
buffer B gradient extending over 214 min.
Mass spectrometry analysis was performed on a Thermo Fusion Tribrid
instrument using the built-in Thermo SPS-MS3 method, with a modiﬁed nano-
HPLC gradient as described above16,17. Brieﬂy, full MS scans were collected in the
orbitrap at 120,000 resolution in a scan range from 380 to 1500m/z. We used an
AGC target of 2.0e5, and a maximum injection time of 50 ms. Peaks were selected
for MS2 based on selection criteria of charge state 2–7 and an intensity threshold of
5.0e3. Dynamic exclusion was enabled, with peaks excluded after 1 scan for a
duration of 70 s in a ±10 ppm window. MS2 was conducted in top speed data-
dependent acquisition mode, with precursor priority given based on highest
intensity. MS2 scans were performed after isolation in the quadrupole using an
isolation window of 0.7m/z units. We used CID activation at a collision energy of
35% for fragmentation. MS2 detection was performed in the ion trap with an AGC
target of 1.0e4 and a maximum injection time of 50 ms. MS2 precursors in the mass
range 400–1200m/z were selected for MS3 analysis using the Thermo TMT reagent
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isobaric tag loss exclusion property and excluding MS2 precursor ions 18m/z units
low and 5m/z units high. MS3 selection was conducted in top 10 data-dependent
acquisition mode giving the most intense ions the highest precursor priority. MS3
ions were selected with synchronous precursor selection activated for 10
precursors. MS and MS2 isolation windows were set to 2m/z. HCD activation was
used at a collision energy of 65%. Fragment ions were detected in the orbitrap with
60,000 resolution in the scan range 120–500m/z. For MS3, we used an AGC target
of 1.0e5 and a maximum injection time of 120 ms.
Mass spectrometry analysis of formaldehyde cross-linking experiments was
performed using a 2 h gradient with chromatography and instrument settings as
reported previously41.
Computational identiﬁcation and quantiﬁcation of proteins. Spectral matching
to peptides, grouping of peptide identiﬁcations into proteins, and isobaric label
quantiﬁcation were performed using Proteome Discoverer 2.1 (Thermo). We used
the built-in processing workﬂow “PWF_Fusion_Reporter_Ba-
sed_Quan_SPS_MS3_SequestHT_Percolator” and the built-in consensus workﬂow
“CWF_Comprehensive_Enhanced Annotation_Quan_Results,” both with default
settings. We used the TMT 10-plex quantiﬁcation method with the 131 mass set as
the control channel. In our workﬂow, the 131 reporter mass always corresponded
to the titration point with the highest bait concentration (3 μM), with each
sequentially lighter reporter tag corresponding to a three-fold dilution of the next
highest bait concentration. For the Sequest HT search, database parameters were
enzymatic digestion with trypsin allowing two missed cleavages, a minimum
peptide length of 6 amino acids and a maximum peptide length of 144 amino acids.
Our search was performed against the uniprot curated human proteome
(downloaded December 2015). We used a precursor mass tolerance of 10 ppm and
a fragment mass tolerance of 0.6 Da. Cysteine carbamidomethylation was included
as a static modiﬁcation (57.021 Da), while methionine oxidation (15.995 Da) and
protein N-terminal acetylation (42.011 Da) were included as dynamic modiﬁca-
tions. We included the 6-plex TMT reagent mass (229.163 Da) as a dynamic
modiﬁcation on lysine, histidine, serine, and threonine, as well as the peptide
N terminus. FDR ﬁltering was performed via percolator with a strict target FDR of
0.01 and a relaxed FDR of 0.0547. Strict parsimony was applied for protein
grouping, and unique plus razor peptides were used for quantiﬁcation. Peptide
quantiﬁcation normalization was applied based on total peptide amount.
For peptide searching taking into account peptide phosphorylation, we
considered serine, threonine, and tyrosine phosphorylation events (79.966 Da) as
possible dynamic modiﬁcations. All other parameters were unchanged.
Peptide identiﬁcation and quantiﬁcation of dimethyl chemical labels for
formaldehyde cross-linking experiments was performed using the MaxQuant
software package48 v1.6.0.1 searching against the UniProt curated human
proteome (released June 2017). Carbamidomethylation was included as a ﬁxed
modiﬁcation and methionine oxidation and protein N-terminal acetylation were
included as variable modiﬁcations. Requantiﬁcation was selected as a quantiﬁcation
parameter. Normalized peptide ratios were transformed to log 2, and replicates
were plotted against each other in two dimensions. Outliers were called based on
inter-quartile ranges using an inter-quartile range of 1.5 in each replicate as a cutoff
value.
HeLa nuclear lysate absolute proteome quantiﬁcation. Absolute abundances of
proteins in HeLa nuclear lysate were reported previously (Supplementary Data 2)22.
Quantiﬁcation was based on the iBAQ method as described previously using
MaxQuant version 1.2.2.548–51.
Fitting of binding parameters and statistical analysis. To calculate protein
binding parameters, we ﬁt a Hill-like curve of the form:
θ ¼ 1
KAppd
L½ 
 n
þ1
; ð1Þ
where θ represents the fraction of protein bound, [L] represents the concentration
of bait, KdApp represents the apparent dissociation constant at which half the
protein is bound to a bait molecule, and n is the Hill coefﬁcient describing the rate
at which binding saturates. θ was observed by calculating the normalized ratio of
each titration point to the 131 reporter ion signal (representing a 3 μM bait con-
centration), implicitly assuming that for each protein that shows KdApp values in
the nanomolar range we would essentially saturate binding at this titration point.
Then, the signal from the 131 reporter ion represented the complete bait binding
population of the entire sample, so the signal from each titration point relative to
the 131 reporter ion represented the fraction bound of the total binding population.
[L] was known from the experimental design. We ﬁt the parameters KdApp and n
using non-linear least squares using the mean θ of each triplicate (SP/KLF oligo
experiments and nucleosome experiments) or duplicate (motif survey experiments
including mycG4 experiments). Proteins were considered for further analysis only
if θ was measured for each titration point of each replicate. θ values from MS3
quantiﬁcation in Proteome Discoverer were normalized by min–max scaling
between 0 and 1. We used initial parameter estimates of KdApp= 100 and n= 1.
After ﬁtting, our data were ﬁltered ﬁrst based on the goodness of ﬁt of the Hill-like
curve. We required a r2 value of 0.95 (0.9 in nucleosome experiments) for a linear
regression between the ﬁt binding model and the measured data, as well as a
predicted fraction bound of <0.25 for the lowest titration point and >0.75 for the
highest titration point. In other words, ﬁt binding curves should match the data
well to avoid spurious ﬁtting, and the binding curve should nearly saturate on both
sides based on the assumptions in the workﬂow described above. For SP/KLF
competition experiments, binding parameters were ﬁt using a Hill-like curve
essentially as described above, using an r2 cutoff of 0.95, to estimate IC50 values.
These IC50 values were then converted to KdApp values using the Cheng–Prusoff
correction:8
KAppd Free ¼
IC50
1þ 200
KApp Immobilizedd
; ð2Þ
where KdApp_Free is the calculated KdApp for either the wild-type or the mutated SP/
KLF oligonucleotide, IC50 is the ﬁt IC50 value from the competition experiment,
and KdApp_Immobilized is the KdApp value calculated from the immobilized SP/KLF
wild-type oligonucleotide experiment. KdApp values identiﬁed in this study are
listed in Supplementary Data 1. Binding curves were plotted as the mean of
replicates plus and minus error bars representing the standard error of the mean
calculated using bootstrapping in the python package seaborn. Clustering of pro-
tein binding proﬁles was performed by hierarchical agglomerative clustering, and
the mean KdApp value of each sample-cluster combination was plotted in a heat-
map. The number of clusters was selected by manual inspection. For statistical
comparisons between multiple members of a complex or complexes, we performed
a two-sided t test treating all measured KdApp values for that complex or paralog
group as sample populations as described in the main text and ﬁgure legends.
Comparison of KdApp and motif score. To compare ﬁtted KdApp values with motif
scores from genome-wide binding models, we ﬁrst collected all vertebrate JASPAR
motifs for factors both with measured KdApp values and identiﬁed in control
experiments with mutated SP/KLF oligonucleotide as sequence-speciﬁc. To
account for intrinsic differences in length and information content of the different
motifs, we calculated the normalized motif score, deﬁned here as the maximum
motif score for the oligo sequence used divided by the patser motif signiﬁcance
threshold in biopython52.
G-quadruplex enrichment in PRC2 and NuRD ChIP-seq peaks. We compared
publically available ChIP-seq data for SWI/SNF, PRC2, and NuRD subunits29,30
with publically available G4-sequencing data31 (Supplementary Table 3). All
sequencing datasets were mapped to the human genome build hg38 using the
UCSC genome browser liftOver tool53. All G4 peaks from the plus and minus
strand with overlapping coordinates were combined using bedtools54. We used
automated permutation-based testing with pybedtools55 to look for signiﬁcant
correlation between ChIP-seq peaks and G4-seq peaks. We randomized ChIP-seq
peaks 1000 times over the genome and each time measured the peak intersection
with G4-sequencing peaks. We then calculated an empirical p value by comparing
the number of true intersected peaks between SWI/SNF, PRC2, or NuRD subunits
and G4-seq peaks with these 1000 randomized intersections.
Protein cloning, expression, and western blotting. DNA pulldowns were
performed as described above for western blotting. For the recombinant SP3 and
SP3+HeLa spike-in pulldowns, 50 ng SP3 protein/pulldown was used, and the
protein binding step was performed in protein binding buffer supplemented with
10 ng/μL bovine serum albumin (BSA) (ﬁnal concentration), 10 μM ZnCl2, and
10% glycerol. After the washing steps, 20 μL sample buffer (1× Laemmli buffer
prepared in a ﬁnal concentration of 6 M urea) was added to each sample. Samples
were incubated for 30 min at 37 °C and resolved by denaturing polyacrylamide gel
electrophoresis. Proteins were transferred to either nitrocellulose or PVDF mem-
branes by semi-dry transfer using the Bio-Rad Trans-Blot Turbo transfer system.
Membranes were blocked in 5% milk for 30 min, and proteins were imaged by
immunoblotting using the Thermo Super Signal Pico PLUS chemiluminescent
substrate.
The recombinant N terminally GST-tagged KLF4-ZF domain was
expressed in BL21 Rosetta (DE3) bacterial cells using 1 mM isopropyl β-D-1-
thiogalactopyranoside induction performed overnight at 16 °C. Two hundred
milliliters of cell culture was collected and incubated in 10 mL lysis buffer
(phosphate-buffered saline (PBS), 0.1% NP-40, 1 mM DTT, CPIs, 10 μM ZnCl2,
2.5 μM MgCl2, 0.25 mg/mL lysozyme, 2 μL benzonase (>500 U)) on ice for 10 min.
Cells were lysed by 30 s rounds of sonication followed by 30 s incubation on ice
until the lysate cleared. Lysates were centrifuged at 4600 × g for 30 min at 4 °C and
the soluble supernatant was immediately added to 150 μL glutathione-agarose
beads that had been prewashed 1× with DBB (Pierce). Ethidium bromide was
added to the supernatant to a ﬁnal concentration of 20 μg/mL, and lysates were
incubated with beads for 1 h while rotating end-over-end at 4 °C. Beads were
washed six times with DBB (1M NaCl) and three times with PBS. GST-tagged
proteins were eluted from the beads with 50 mM reduced glutathione in PBS.
Eluted proteins were dialyzed into PBS (+10 μM ZnCl2) twice over 2 h at 4 °C
before a ﬁnal dialysis overnight into PBS (+10 μM ZnCl2) at 4 °C using
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Slide-A-Lyzer dialysis cassettes (10,000 molecular weight cut-off, 0.1–0.5 mL
volume, Thermo). NP-40 was added to 0.1% and DDT was added to 1 mM, while
NaCl was adjusted to 400 mM in PBS for storage. Protein concentration was
measured by UV absorbance at 280 nM and by the Bradford assay. KLF4-ZF
experiments were repeated after dialyzing GST-KLF4-ZF into PBS with no
additions, and similar results were observed.
The PHF10 C-terminal double PHD ﬁnger domain and the SMARCB1
N-terminal WHD were N terminally GST-tagged during ligation-based cloning,
expressed in BL21 Rosetta (DE3) bacteria, and used for H3 peptide pulldowns as
described previously56. Antibodies and dilutions used in this study are listed in
Supplementary Table 2, and raw gel images are shown in Supplementary Fig. 11.
Electrophoretic mobility shift assays. For EMSA experiments probing for
endogenous protein from HeLa lysates, only PBB was used as the incubation
buffer. DNA oligos were diluted in PBB as described above and incubated with
~0.75 μg/μL HeLa nuclear lysate for 15 min at room temperature. Binding reactions
were then resolved by native polyacrylamide gel electrophoresis in 0.5× TBE
(Tris-borate-EDTA) running buffer. Protein transfer and immunoblotting was
performed as described above. For EMSAs using puriﬁed recombinant SP3, the
oligo dilution and protein binding steps were performed in protein binding buffer
supplemented with 10 ng/μL BSA (ﬁnal concentration), 10 μM ZnCl2, and 10%
glycerol. One hundred nanograms of SP3 protein per reaction was used for the
recombinant SP3 EMSA. Recombinant proteins used in this study are listed in
Supplementary Table 2.
For KLF4-ZF EMSA experiments, proteins were prepared with DNA based on
molar concentration as shown in Supplementary Fig. 3C in PBS. Binding reactions
were incubated for 15 min at room temperature and resolved on a 1% agarose gel
using 0.5× TAE (Tris-acetate-EDTA) running buffer. The agarose gel was washed
for 5 min in distilled water, stained for 30 min with 0.5 μg/mL ethidium bromide,
and destained for 5 min in distilled water before imaging.
Fluorescence polarization and ﬂuorescence intensity assays. Fluorescence
polarization and intensity experiments were performed largely as described
previously19,20. SP/KLF wild-type oligonucleotides were ordered with a 5′ Cy5
ﬂuorescent label on each strand (IDT). Labeled oligonucleotides were annealed as
described above and diluted to 2 nM in PBS. Recombinant KLF4-ZF was diluted
using PBS to a three-fold dilution series of ten concentrations from 0.3 nM to 6 μM
in a Greiner black, 96-well non-binding microplate. Recombinant KLF4-ZF and
labeled oligonucleotides were mixed at a ratio of 1:1 in a ﬁnal volume of 200 μL,
with labeled oligonucleotides at a ﬁnal concentration of 1 nM and recombinant
KLF4-ZF at a ﬁnal concentration range of 0.15 nM to 3 μM. Binding reactions were
incubated for 20 min at room temperature, and ﬂuorescence polarization and
intensity were measured at 25 °C on a Tecan Spark 10M microplate reader.
Baseline polarization was calibrated based on protein-free reference samples to 50
mP. Wells were measured with 200 ﬂashes per well and a 1 s settling time per
sample. Binding assays were performed in triplicate, and binding parameters were
calculated and plotted as described above using a Hill-like function.
Data availability. The mass spectrometry proteomics data have been deposited to
the ProteomeXchange Consortium via the PRIDE partner repository57 with the
dataset identiﬁer PXD007132. All other relevant data are available from the
corresponding authors.
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